Cited by 91Dementia and Cognitive Impairment ResearchBlood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans

Open access
Levine, Deborah A., Galecki, Andrzej T., Langa, Kenneth M., Unverzagt, Frederick W., Kabeto, Mohammed U., Giordani, Bruno, Cushman, Mary, McClure, Leslie A. +2 more·2019·Hypertension

Abstract

Although the association between high blood pressure (BP), particularly in midlife, and late-life dementia is known, less is known about variations by race and sex. In a prospective national study of 22 164 blacks and whites ≥45 years without baseline cognitive impairment or stroke from the REGARDS cohort study (Reasons for Geographic and Racial Differences in Stroke), enrolled 2003 to 2007 and followed through September 2015, we measured changes in cognition associated with baseline systolic and diastolic BP (SBP and DBP), as well as pulse pressure (PP) and mean arterial pressure, and we tested whether age, race, and sex modified the effects. Outcomes were global cognition (Six-Item Screener; primary outcome), new learning (Word List Learning), verbal memory (Word List Delayed Recall), and executive function (Animal Fluency Test). Median follow-up was 8.1 years. Significantly faster declines in global cognition were associated with higher SBP, lower DBP, and higher PP with increasing age ( P<0.001 for age×SBP×follow-up-time, age×DBP×follow-up-time, and age×PP×follow-up-time interaction). Declines in global cognition were not associated with mean arterial pressure after adjusting for PP. Blacks, compared with whites, had faster declines in global cognition associated with SBP ( P=0.02) and mean arterial pressure ( P=0.04). Men, compared with women, had faster declines in new learning associated with SBP ( P=0.04). BP was not associated with decline of verbal memory and executive function, after controlling for the effect of age on cognitive trajectories. Significantly faster declines in global cognition over 8 years were associated with higher SBP, lower DBP, and higher PP with increasing age. SBP-related cognitive declines were greater in blacks and men.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.118.12062

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Systolic BP varies by sex.

    “We required participants to have 1 or more assessments of cognition and 1 or more measurements of blood pressure (BP) at or before the first measurement of cognition because BP is a risk factor for cognitive decline11,18 and varies by sex.18,19”

    From Sex differences in cognitive decline among US adults (2021) · cites this paper as [18]

    The Introduction (page unavailable) says men are more likely than women to have high blood pressure before age 50, with the disparity narrowing and reversing at older ages. That supports a sex difference in high blood pressure, but the passage does not establish that systolic blood pressure specifically varies by sex. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Systolic BP is a risk factor for cognitive decline.

    “We required participants to have 1 or more assessments of cognition and 1 or more measurements of blood pressure (BP) at or before the first measurement of cognition because BP is a risk factor for cognitive decline11,18 and varies by sex.18,19”

    From Sex differences in cognitive decline among US adults (2021) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. [2]Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Prevalence of cognitive impairment without dementia in the United States. Annals of internal medicine. 2008; 148: 427– 434 18347351 PMC2670458
  2. [4]Alzheimer’s A 2014 Alzheimer’s Disease Facts and Figures. Alzheimer’s & dementia. 2014; 10: e47– 92 24818261
  3. [5]Conference and recommendations report to the National Institute of Neurological Disorders and Stroke Council. Alzheimer’s Disease-Related Dementias: Research Challenges and Opportunities September 13, 2013 Available at: http://www.ninds.nih.gov/news_and_events/proceedings/adrd2013.htm Accessed July 18, 2018.
  4. [6]Alzheimer’s Association. Study shows intensive blood pressure control reduces risk of mild cognitive impairment (MCI) and the combined risk of MCI and dementia.Alzheimer’s Association International Conference 2018 July 25, 2018 Available at: https://www.alz.org/aaic/downloads2018/Wed-am-briefing-developing-topics.pdf Accessed September 4, 2018.
  5. [7]Elias MF, Goodell AL, Dore GA. Hypertension and cognitive functioning: A perspective in historical context. Hypertension. 2012; 60: 260– 268 22753214
  6. [8]Levine DA, Lewis CE, Williams OD, Safford MM, Liu K, Calhoun DA, Geographic and demographic variability in 20-year hypertension incidence: The cardia study. Hypertension. 2011; 57: 39– 47 21135358 PMC3057218
  7. [9]Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Management of high blood pressure in blacks: An update of the International Society on Hypertension in blacks consensus statement. Hypertension. 2010; 56: 780– 800 20921433
  8. [10]Birns J, Morris R, Jarosz J, Markus H, Kalra L. Ethnic differences in the cerebrovascular impact of hypertension. Cerebrovascular diseases. 2008; 25: 408– 416 18349534
  9. [11]Brickman AM, Schupf N, Manly JJ, Luchsinger JA, Andrews H, Tang MX, Brain morphology in older african americans, caribbean hispanics, and whites from northern manhattan. Archives of neurology. 2008; 65: 1053– 1061 18695055 PMC2692286
  10. [12]Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA internal medicine. 2013; 173: 46– 51 23229778 PMC3759226
  11. [13]Marcus J, Gardener H, Rundek T, Elkind MS, Sacco RL, Decarli C, Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: The Northern Manhattan Study. Stroke. 2011; 42: 2639– 2641 21836088 PMC3189513
  12. [14]Hajjar I, Rosenberger KJ, Kulshreshtha A, Ayonayon HN, Yaffe K, Goldstein FC. Association of JNC-8 and sprint systolic blood pressure levels with cognitive function and related racial disparity. JAMA neurology. 2017; 74: 1199– 1205 28828478 PMC5710237
  13. [15]Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, Midlife hypertension and 20-year cognitive change: The Atherosclerosis Risk In Communities Neurocognitive Study. JAMA neurology. 2014; 71: 1218– 1227 25090106 PMC4226067
  14. [16]Gilsanz P, Mayeda ER, Glymour MM, Quesenberry CP, Mungas DM, DeCarli C, Female sex, early-onset hypertension, and risk of dementia. Neurology. 2017; 89: 1886– 1893 28978656 PMC5664296
  15. [17]Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4: 487– 499 16033691
  16. [18]Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, The REasons for Geographic And Racial Differences in Stroke study: Objectives and design. Neuroepidemiology. 2005; 25: 135– 143 15990444
  17. [21]Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) clinical and neuropsychological assessment of Alzheimer’s disease. Psychopharmacology bulletin. 1988; 24: 641– 652 3249766
  18. [22]Unverzagt FW, Monahan PO, Moser LR, Zhao Q, Carpenter JS, Sledge GW Jr., The Indiana University telephone-based assessment of neuropsychological status: A new method for large scale neuropsychological assessment. Journal of the International Neuropsychological Society: JINS. 2007; 13: 799– 806 17697411 PMC2747375
  19. [23]Rapp SR, Legault C, Espeland MA, Resnick SM, Hogan PE, Coker LH, Validation of a cognitive assessment battery administered over the telephone. Journal of the American Geriatrics Society. 2012; 60: 1616– 1623 22985137 PMC3448122
  20. [24]Wilson RS, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Mayeux R, Telephone assessment of cognitive function in the Late-onset Alzheimer’s Disease Family Study. Archives of neurology. 2010; 67: 855– 861 20625093 PMC2971664
  21. [26]Lucas JA, Ivnik RJ, Smith GE, Ferman TJ, Willis FB, Petersen RC, Mayo’s Older African Americans Normative Studies: Norms for boston naming test, controlled oral word association, category fluency, animal naming, token test, wrat-3 reading, trail making test, stroop test, and judgment of line orientation. The Clinical neuropsychologist. 2005; 19: 243– 269 16019707
  22. [27]Levine DA, Calhoun DA, Prineas RJ, Cushman M, Howard VJ, Howard G. Moderate waist circumference and hypertension prevalence: The REGARDS study. American journal of hypertension. 2011; 24: 482– 488 21233800 PMC3717383
  23. [28]Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation. 2016; 133: e38– e360 26673558
  24. [29]Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Trajectory of cognitive decline after incident stroke. JAMA. 2015; 314: 41– 51 26151265 PMC4655087
  25. [30]Kohler S, Baars MA, Spauwen P, Schievink S, Verhey FR, van Boxtel MJ. Temporal evolution of cognitive changes in incident hypertension: Prospective cohort study across the adult age span. Hypertension. 2014; 63: 245– 251 24296281
  26. [31]Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903– 1913 12493255
  27. [32]Qiu C, Winblad B, Viitanen M, Fratiglioni L. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke. 2003; 34: 594– 599 12624277
  28. [33]Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J Clin Epidemiol. 2005; 58: 1308– 1315 16291476
  29. [34]Wolinsky FD, Unverzagt FW, Smith DM, Jones R, Stoddard A, Tennstedt SL. The active cognitive training trial and health-related quality of life: Protection that lasts for 5 years. The journals of gerontology. Series A, Biological sciences and medical sciences. 2006; 61: 1324– 1329 17234829
  30. [36]Unger JM, van Belle G, Heyman A. Cross-sectional versus longitudinal estimates of cognitive change in nondemented older people: A CERAD study. Consortium to Establish a Registry for Alzheimer’s Disease. Journal of the American Geriatrics Society. 1999; 47: 559– 563 10323649
  31. [37]Bennett HP, Corbett AJ, Gaden S, Grayson DA, Kril JJ, Broe GA. Subcortical vascular disease and functional decline: A 6-year predictor study. Journal of the American Geriatrics Society. 2002; 50: 1969– 1977 12473008
  32. [40]Coleman CG, Wang G, Faraco G, Marques Lopes J, Waters EM, Milner TA, Membrane trafficking of nadph oxidase p47(phox) in paraventricular hypothalamic neurons parallels local free radical production in angiotensin ii slow-pressor hypertension. The Journal of neuroscience. 2013; 33: 4308– 4316 23467347 PMC3616374
  33. [42]Wang R, Fratiglioni L, Laukka EJ, Lovden M, Kalpouzos G, Keller L, Effects of vascular risk factors and APOE epsilon4 on white matter integrity and cognitive decline. Neurology. 2015; 84: 1128– 1135 25672924 PMC4371409
  34. [43]Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC 3rd. Increased incidence of neurofibrillary tangles (nft) in non-demented individuals with hypertension. Journal of the neurological sciences. 1995; 131: 162– 169 7595642
  35. [44]Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiol Aging. 2000; 21: 49– 55 10794848
  36. [45]Salthouse TA. Selectivity of attrition in longitudinal studies of cognitive functioning. The journals of gerontology. Series B, Psychological sciences and social sciences. 2014; 69: 567– 574 PMC4049149 23733858
  37. [47]Gross AL, Benitez A, Shih R, Bangen KJ, Glymour MM, Sachs B, Predictors of retest effects in a longitudinal study of cognitive aging in a diverse community-based sample. Journal of the International Neuropsychological Society: JINS. 2015; 21: 506– 518 26527240 PMC4783169

Cited by

Sorted by citations

Authors
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., Cushman, M., McClure, L. A., Safford, M. M., & Wadley, V. G.
Affiliations
  • University of Michigan (US)
  • From the Department of Internal Medicine (D.A.L., A.T.G., K.M.L., M.U.K.), University of Michigan Medical School, Ann Arbor
  • Indiana University Indianapolis (US)
  • University of Vermont (US)
  • Drexel University (US)
  • Weill Cornell Medicine (US)
  • University of Alabama at Birmingham (US)
Venue
Hypertension
Published
2019-02
Volume
73
Issue
2
Pages
310-318
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2910684962
Cited by
91
References
11
Citations by year
2026: 7 · 2025: 13 · 2024: 10 · 2023: 13 · 2022: 15 · 2021: 14 · 2020: 16 · 2019: 3
FWCI
9.56
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • PMC
Funders
  • National Institute on Aging (P30AG053760, R01AG051827, P30AG024824)
  • National Institute of Neurological Disorders and Stroke (U01NS041588, R01NS102715)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
blood pressure, cognitive decline, systolic blood pressure, diastolic blood pressure, pulse pressure, mean arterial pressure, racial differences, sex differences, African Americans, middle-aged and older adults, global cognition, verbal memory, executive function, learning, REGARDS cohort
MeSH terms
Age Factors, Aged, Blood Pressure, Female, Humans, Male, Memory, Middle Aged, Prospective Studies, Black People, White People, Executive Function, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review